Palisade Bio, Inc. PALI Q3 2025 earnings
Reported November 10, 2025 · Before market open
EPS-$0.38Miss by $0.06
EPS estimate-$0.32
Next report
Aug 10, 2026 (In 1 week)EPS estimate-$0.05
Versus estimates
Revenue
Diluted EPS
Ask the moment Palisade Bio, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Palisade Bio, Inc. report Q3 2025 earnings?
- Palisade Bio, Inc. (PALI) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Palisade Bio, Inc.'s Q3 2025 revenue and EPS?
- Palisade Bio, Inc. reported eps of $-0.38 for Q3 2025.
- Did Palisade Bio, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.32 by $0.06.
- How did Palisade Bio, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 83.6% from $-2.32.
- Where can I find Palisade Bio, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-274262) directly on SEC EDGAR. The filing index links above go to sec.gov.